Azmi Yerlikaya
Kutahya, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
HRI Kinase Modulation by BTdCPU as a Therapeutic Strategy for Bortezomib Resistance in Prostate Cancer.
Journal: Current medicinal chemistry
Published: February 19, 2026
Spermine synthase in Snyder-Robinson syndrome and cancer.
Journal: Molecular biology reports
Published: August 25, 2025
Comparative Investigation of Cytotoxic Effects of Structurally Diverse Small Molecules and In Silico Analysis of 1-Acetyl-4-(4-Hydroxyphenyl)piperazine.
Journal: Journal of cellular and molecular medicine
Published: July 16, 2025
Boron's Role in B16-F10 Melanoma: Cytotoxic, Antioxidant, Apoptotic, and Anti-inflammatory Effects.
Journal: Biological trace element research
Published: April 16, 2025
Polyamines in Cancer: Mechanisms, Metabolic Targets, and Therapeutic Opportunities.
Journal: Anti-cancer agents in medicinal chemistry
Published: February 22, 2025
Targeting BMP-1 enhances anti-tumoral effects of doxorubicin in metastatic mammary cancer: common and distinct features of TGF-β inhibition.
Journal: Breast cancer research and treatment
Published: October 20, 2024
Comparative Analysis of Acquired Resistance to Bortezomib in Prostate Cancer Cells Using Proteomic and Bioinformatic Tools.
Journal: Journal of cellular and molecular medicine
Published: July 13, 2024
Label-free nLC-MS/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosa.
Journal: Medical oncology (Northwood, London, England)
Published: June 02, 2023
Heme-regulated inhibitor: an overlooked eIF2α kinase in cancer investigations.
Journal: Medical oncology (Northwood, London, England)
Published: December 30, 2021
Molecular Pathways, Targeted Therapies, and Proteomic Investigations of Colorectal Cancer.
Journal: Current molecular medicine
Published: July 29, 2021
Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line.
Journal: Medical oncology (Northwood, London, England)
Published: July 01, 2021
The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer.
Journal: Anti-cancer agents in medicinal chemistry
Published: March 04, 2020
Last Updated: 09/26/2026